Reduced airway inflammation and remodeling in parallel with mucin 5AC protein expression decreased by S-carboxymethylcysteine, a mucoregulant, in the airways of rats exposed to sulfur dioxide

International Archives of Allergy and Immunology

Volumn 134, Issue 4, 2004, Pages 273-280

  Sueyoshi, Sumihisa ^a   Miyata, Yuki ^a   Masumoto, Yoshihiro ^a   Ishibashi, Yuji ^a   Matsuzawa, Shigeki ^a   Harano, Naoki ^a   Tsuru, Kiyoyuki ^a   Imai, Shigeru ^a  

^a KYORIN PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Airway inflammation; Alcian blue (pH 2.5) periodic acid Schiff; Goblet cell hyperplasia; Mucin 5AC immunohistochemistry; S carboxymethylcysteine

Indexed keywords

BIOLOGICAL MARKER; CARBOCISTEINE; MUCIN 5AC; SULFUR DIOXIDE;

AIRWAY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHITIS; CELL INFILTRATION; CONTROLLED STUDY; DISEASE MARKER; DRUG EFFECT; EXPERIMENTAL MODEL; GOBLET CELL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MALE; MORPHOMETRICS; MUCUS SECRETION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFLAMMATION; TISSUE DISTRIBUTION;

AIR POLLUTANTS; ANIMALS; BRONCHITIS; CARBOCYSTEINE; DISEASE MODELS, ANIMAL; EXPECTORANTS; GOBLET CELLS; IMMUNOHISTOCHEMISTRY; INHALATION EXPOSURE; MALE; MUCINS; RATS; RATS, WISTAR; RESPIRATORY MUCOSA; SULFUR DIOXIDE;

EID: 4043058617     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079164     Document Type: Article

References (31)

1. Aikawa T, Shimura S, Sasaki H, Ebina M, Takishima T: Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. Chest 1992;101:916-921.
2. Jeffery PK, Li D: Airway mucosa: Secretory cells, mucus and mucin genes. Eur Respir J 1997;10:1655-1662.
3. Jeffery PK: Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 2001;164:S28-S38.
4. Behrendt H, Becker WM, Fritzsche C, Sliwa-Tomczok W, Tomczok J, Friedrichs KH, Ring J: Air pollution and allergy: Experimental studies on modulation of allergen release from pollen by air pollutants. Int Arch Allergy Immunol 1997;113:69-74.
5. Lamb D, Reid L: Mitotic rates, goblet cell increase and histochemical changes in mucus in rat bronchial epithelium during exposure to sulphur dioxide. J Pathol Bacteriol 1968;96:97-111.
6. 2. Lab Invest 1973;29:41-53.
7. White R, Zoppi AL, Haroz RK, Broillet A: Sulfur dioxide induced bronchitis in rats. Arch Toxicol 1986;9:431-435.
8. Kodavanti UP, Mebane R, Ledbetter A, Krantz T, McGee J, Jackson MC, Walsh L, Hilliard H, Chen BY, Richards J, Costa DL: Variable pulmonary responses from exposure to concentrated ambient air particles in a rat model of bronchitis. Toxicol Sci 2000;54:441-451.
9. Rose MC, Gendler SJ: Airway mucin genes and gene products; in Rogers DF, Lethem MI (eds): Airway Mucus: Basic Mechanisms and Clinical Perspectives. Basel, Birkhäuser, 1997, pp 41-66.
10. Alimam MZ, Piazza FM, Selby DM, Letwin N, Huang L, Rose MC: Muc-5/5ac mucin messenger RNA and protein expression is a marker of goblet cell metaplasia in murine airways. Am J Respir Cell Mol Biol 2000;22:253-260.
11. Ordonez CL, Khashayar R, Wong HH, Ferrando R, Wu R, Hyde DM, Hotchkiss JA, Zhang Y, Novikov A, Dolganov G, Fahy JV: Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression. Am J Respir Crit Care Med 2001;163:517-523.
12. Harkema JR, Hotchkiss JA, Henderson RF: Effects of 0.12 and 0.80 ppm ozone on rat nasal and nasopharyngeal epithelial mucosubstances: Quantitative histochemistry. Toxicol Pathol 1989;17:525-535.
13. Harkema JR, Hotchkiss JA: In vivo effects of endotoxin on nasal epithelial mucosubstances: Quantitative histochemistry. Exp Lung Res 1991;17:743-761.
14. Steiger D, Hotchkiss J, Bajaj L, Harkema J, Basbaum C: Concurrent increases in the storage and release of mucin-like molecules by rat airway epithelial cells in response to bacterial endotoxin. Am J Respir Cell Mol Biol 1995;12:307-314.
15. Basbaum C, Gallup M, Gum J, Kim Y, Jany B: Modification of mucin gene expression in the airways of rats exposed to sulfur dioxide. Biorheology 1990;27:485-489.
16. Jany B, Gallup M, Tsuda T, Basbaum C: Mucin gene expression in rat airways following infection and irritation. Biochem Biophys Res Commun 1991;181:1-8.
17. Edwards GF, Steel AE, Scott JK, Jordan JW: S-carboxymethylcysteine in the fluidification of sputum and treatment of chronic airway obstruction. Chest 1976;70:506-513.
18. Puchelle E, Aug F, Polu JM: Effect of the mucoregulator S-carboxy-methyl-cysteine in patients with chronic bronchitis. Eur J Clin Pharmacol 1978;14:177-184.
19. Poole PJ, Black PN: Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: Systematic review. BMJ 2001;322:1271-1274.
20. Brown DT: Carbocysteine. Drug Intell Clin Pharm 1988;22:603-608.
21. Sadakane K, Ichinose T, Takano H, Yanagisawa R, Sagai M, Yoshikawa T, Shibamoto T: Murine strain differences in airway inflammation induced by diesel exhaust particles and house dust mite allergen. Int Arch Allergy Immunol 2002;128:220-228.
22. Hotchkiss JA, Harkema JR, Henderson RF: Effect of cumulative ozone exposure on ozone-induced nasal epithelial hyperplasia and secretory metaplasia in rats. Exp Lung Res 1991;15:589-600.
23. Martin R, Litt M, Marriott C: The effect of mucolytic agents on the rheologic and transport properties of canine tracheal mucus. Am Rev Respir Dis 1980;121:495-500.
24. Asti C, Melillo G, Caselli GF, Daffonchio L, Hernandez A, Clavenna G, Omini C: Effectiveness of carbocysteine lysine salt monohydrate on models of airway inflammation and hyperresponsiveness. Pharmacol Res 1995;31:387-392.
25. Ishii Y, Kimura T, Morishima Y, Mochizuki M, Nomura A, Sakamoto T, Uchida Y, Sekizawa K: S-carboxymethylcysteine inhibits neutrophil activation mediated by N-formyl-methionyl-leucyl-phenylalanine. Eur J Pharmacol 2002;449:183-189.
26. Knorst MM, Kienast K, Muller-Quernheim J, Ferlinz R: Effect of sulfur dioxide on cytokine production of human alveolar macrophages in vitro. Arch Environ Health 1996;51:150-156.
27. Gong H Jr, Linn WS, Terrell SL, Anderson KR, Clark KW: Anti-inflammatory and lung function effects of montelukast in asthmatic volunteers exposed to sulfur dioxide. Chest 2001;119:402-408.
28. Kodavanti UP, Jackson MC, Ledbetter AD, Starcher BC, Evansky PA, Harewood A, Winsett DW, Costa DL: The combination of elastase and sulfur dioxide exposure causes COPD-like lesions in the rat. Chest 2000;117:299S-302S.
29. Fahy JV: Goblet cell and mucin gene abnormalities in asthma. Chest 2002;122:320S-326S.
30. Voynow JA: What does mucin have to do with lung disease? Paediatr Respir Rev 2002;3:98-103.
31. Plopper CG, Weir A, George JS, Tyler N, Mariassy A, Wilson D, Nishio S, Cranz D, Heidsiek J, Hyde D: Cell populations of the respiratory system: Interspecies diversity in composition, distribution, and morphology; in Mohr U, Dungworth D, Kimmerle G, Lewkowski J, McClellan R, Stöber W (eds): Inhalation toxicology. New York, Springer, 1988, pp 25-40.